iThrive Beyond Cancer против RunRA Использование & Stats
iThrive is a mobile app to address fear of cancer recurrence through a series of customized cognitive exercises.
After a cancer diagnosis, people may interpret their worlds in a different way, particularly when they are not sure what a situation or symptom might mean. They are often told to contact their medical team when they start to experience certain symptoms and given the message that these might be cause for concern. However, even after the treatment has ended, many cancer survivors continue to interpret physical symptoms and different situations as threatening, worried that they might be a sign of their cancer coming back. Some level of worry is normal and helpful as it is important to be aware of potential signs of recurrence. However, for some survivors, this worry can take over and prevent them from engaging fully in their lives.
iThrive is designed to reduce fear of cancer recurrence by retraining certain thinking patterns so that survivors can develop new, helpful mental habits. It does this through repeated practice of alternative interpretations of situations that are personally anxiety-provoking. Promoting a new way of thinking requires many practice trials, which helps these mental habits become more natural and automatic -- that’s why exercises offered through iThrive involve repetition.
To obtain best results from iThrive, after completing the personalization items, follow your individual session schedule. You can set up reminders through the app to help ensure you complete the exercises as scheduled.
iThrive uses Apple's ResearchKit API which integrates with Apple's Health Kit to run an Active Task. However iThrive does NOT access any user health data from the device. iThrive does collect response time to stimuli as part of the research trial which users have consented too.
- Apple App Store
- Бесплатный
- Медицина
Рейтинг магазина
- -
RunRA is a mobile application designed with patients for patients. The patients who assisted in the app development, together, had more than 50 years of experience living with rheumatoid arthritis. This app enables personalized tracking of disease activity, goal setting, and notetaking that support development of strategies for dealing with of symptom and side effects of rheumatoid arthritis. The app tracks disease activity using a standard measure widely accepted by rheumatologists and other providers– RAPID-3. The RAPID-3 provides a score from 0 to 10 based on responses to a set of 12 questions. Patients can record their disease activity daily or more frequently to show the course over any period of time: days, weeks, months or years, as the information can be displayed graphically for the length of time the app user selects. Users can enter and prioritize their personalized goals for living with their disease to aide in communication with the rheumatologist or other provider about a treatment plan that will allow those goals to be achieved. Additionally, symptom and side effect priorities can be recorded to assist with their provider discussions as to a treatment plan that allows achieving treatment goals while controlling high priority symptoms and minimizing high priority side effects. The user also can enter notes to assist in recalling problematic symptoms and side-effects and that can be viewed alongside points in the disease trajectory. This allows app users to understand holistically, and to concisely convey to their provider, how the disease is affecting daily living and goal attainment.
- Apple App Store
- Бесплатный
- Здоровье & Фитнес
Рейтинг магазина
- -
iThrive Beyond Cancer vs. RunRA ranking comparison
Compare iThrive Beyond Cancer ranking trend in the past 28 days vs. RunRA
Rank
Нет данных
Рейтинг iThrive Beyond Cancer против RunRA в сравнении по странам
Сравните динамику рейтинга iThrive Beyond Cancer за последние 28 дней с динамикой рейтинга RunRA.
Нет данных для отображения
Сравните данные с любым сайтом, воспользовавшись бесплатной пробной версией
iThrive Beyond Cancer VS.
RunRA
декабрь 26, 2024